by Dr. Raymond Oenbrink | Addiction
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2715617 Comment; Improved survival with surgical approaches and referral to addiction treatment during the inpatient setting. Good to know Laura Rodger, MD1; Stephannie...
by Dr. Raymond Oenbrink | Addiction
https://www.nastad.org/resource/supervised-injection-facilities-recommendations-action America’s opioid epidemic continues to cause unprecedented overdose deaths and fuel increases in new cases of hepatitis B and C, and HIV. According to the CDC, in 2016 over 64,000...
by Dr. Raymond Oenbrink | Addiction
http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2017.304132 Jon E. Zibbell PhD, Alice K. Asher PhD, Rajiv C. Patel MPH, Ben Kupronis MPH, Kashif Iqbal MPH, John W. Ward MD, and Deborah Holtzman PhD Objectives. To compare US trends in rates of injection drug use...
by Dr. Raymond Oenbrink | Addiction
Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment By Michelle Andrews Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn’t qualify yet for the Medicaid...
by Dr. Raymond Oenbrink | Addiction
https://sciforschenonline.org/journals/hiv-aids/article-data/JHA-3-141/JHA-3-141.pdf Erika Castro*1 and Claire Elise Burdet1,2 Abstract Chronic hepatitis C virus infection is a global epidemic mainly affecting Eastern Mediterranean and European Regions with 2.3% and...
by Dr. Raymond Oenbrink | Addiction
https://www.cdc.gov/mmwr/volumes/66/wr/mm6618a3.htm?s_cid=mm6618a3_w Summary What is already known about this topic? Hepatitis C virus (HCV) infection affects approximately 3.5 million persons in the United States, making it the most common bloodborne infection in the...
